Nurix Therapeutics annual debt-to-equity ratio
2021
2022
2023
2024
2025
Nurix Therapeutics Debt-to-Equity Ratio Growth & History (NRIX)
Nurix Therapeutics's debt-to-equity ratio was 0.10 for fiscal 2025.
View full Nurix Therapeutics company overviewNurix Therapeutics annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-11-30 | 0.10 | 0.05 | +92.61% |
| 2024 | 2024-11-30 | 0.05 | −0.10 | −64.83% |
| 2023 | 2023-11-30 | 0.15 | 0.11 | +287.60% |
| 2022 | 2022-11-30 | 0.04 | 0.00 | +3.44% |
| 2021 | 2021-11-30 | 0.04 | — | — |
Nurix Therapeutics quarterly debt-to-equity ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-05-31 | 0.14 | 0.03 | +24.47% |
| Q1 2026 | 2026-02-28 | 0.12 | 0.07 | +120.33% |
| Q4 2025 | 2025-11-30 | 0.10 | 0.05 | +92.61% |
| Q3 2025 | 2025-08-31 | 0.15 | 0.08 | +110.68% |
| Q2 2025 | 2025-05-31 | 0.12 | 0.04 | +49.23% |
| Q1 2025 | 2025-02-28 | 0.06 | −0.12 | −67.96% |
| Q4 2024 | 2024-11-30 | 0.05 | −0.10 | −64.83% |
| Q3 2024 | 2024-08-31 | 0.07 | 0.04 | +110.40% |
| Q2 2024 | 2024-05-31 | 0.08 | 0.04 | +116.33% |
| Q1 2024 | 2024-02-29 | 0.17 | 0.13 | +344.10% |
| Q4 2023 | 2023-11-30 | 0.15 | 0.11 | +287.60% |
| Q3 2023 | 2023-08-31 | 0.03 | −0.00 | −11.44% |
| Q2 2023 | 2023-05-31 | 0.04 | −0.02 | −33.95% |
| Q1 2023 | 2023-02-28 | 0.04 | −0.01 | −24.46% |
| Q4 2022 | 2022-11-30 | 0.04 | 0.00 | +3.44% |
| Q3 2022 | 2022-08-31 | 0.04 | — | — |
| Q2 2022 | 2022-05-31 | 0.05 | — | — |
| Q1 2022 | 2022-02-28 | 0.05 | — | — |
| Q4 2021 | 2021-11-30 | 0.04 | — | — |
Nurix Therapeutics debt-to-equity ratio trends
Between the periods ended 2021-11-30 and 2025-11-30, Nurix Therapeutics's debt-to-equity ratio increased from 0.04 to 0.10, a change of 0.07. The latest reported quarter, Q2 2026, shows 0.14.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nurix Therapeutics source filings ↗